Cargando…

Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development

CDKN2A coding region germline variants are associated with pancreatic adenocarcinoma (PC) susceptibility. Recently, we described functional germline 5’UTR CDKN2A variants from melanoma patients affecting the post-transcriptional regulation of p16(INK4a) mRNA that is dependent, at least in part, on a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruno, William, Andreotti, Virginia, Bisio, Alessandra, Pastorino, Lorenza, Fornarini, Giuseppe, Sciallero, Stefania, Bianchi-Scarrà, Giovanna, Inga, Alberto, Ghiorzo, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720692/ https://www.ncbi.nlm.nih.gov/pubmed/29216274 http://dx.doi.org/10.1371/journal.pone.0189123

Ejemplares similares

Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients
por: Puccini, Alberto, et al.
Publicado: (2022)

The 5′-untranslated region of p16(INK4a) melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding
por: Bisio, Alessandra, et al.
Publicado: (2015)

Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry
por: Bruno, William, et al.
Publicado: (2016)

Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
por: Helgadottir, Hildur, et al.
Publicado: (2020)

Pancreatic Cancer: From Genetic Mechanisms to Translational Challenges
por: Pastorino, Lorenza, et al.
Publicado: (2023)

Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients
por: Dalmasso, Bruna, et al.
Publicado: (2022)

Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations
por: Bruno, William, et al.
Publicado: (2017)

Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations
por: Bruno, William, et al.
Publicado: (2018)

Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome
por: Pastorino, Lorenza, et al.
Publicado: (2012)

Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants
por: Spagnolo, Francesco, et al.
Publicado: (2021)

Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
por: Vanni, Irene, et al.
Publicado: (2020)

Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A
por: Llach, Joan, et al.
Publicado: (2023)

Insights into Mechanisms of Tumorigenesis in Neuroendocrine Neoplasms
por: Pastorino, Lorenza, et al.
Publicado: (2021)

Analysis of sequence variants in the 3'UTR of CDKN2A gene in melanoma patients
por: Przybyła, Anna, et al.
Publicado: (2015)

Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism
por: Mazarico-Altisent, I., et al.
Publicado: (2022)

BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies
por: Spagnolo, Francesco, et al.
Publicado: (2015)

Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors
por: Campa, Daniele, et al.
Publicado: (2016)

Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of CDKN2A Pathogenic Variants
por: Pauley, Kristen, et al.
Publicado: (2022)

CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation
por: Torre, G Della, et al.
Publicado: (2001)

Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients
por: Ciccarese, Giulia, et al.
Publicado: (2020)

Pancreatic adenosquamous carcinoma and intraductal papillary mucinous neoplasm in a CDKN2A germline mutation carrier
por: Martínez de Juan, Fernando, et al.
Publicado: (2017)

Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1
por: Pastorino, Lorenza, et al.
Publicado: (2020)

The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
por: Vanni, Irene, et al.
Publicado: (2020)

Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
por: Chan, Sock Hoai, et al.
Publicado: (2016)

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)
por: Vanni, Irene, et al.
Publicado: (2020)

Current State of Target Treatment in BRAF Mutated Melanoma
por: Tanda, Enrica Teresa, et al.
Publicado: (2020)

p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast-Based Screening System
por: Andreotti, Virginia, et al.
Publicado: (2011)

A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition
por: Horn, Isaac P., et al.
Publicado: (2021)

CDKN2A germline alterations and the relevance of genotype-phenotype associations in cancer predisposition
por: Chan, Sock Hoai, et al.
Publicado: (2021)

Regulation of male germline transmission patterns by the Trp53-Cdkn1a pathway
por: Kanatsu-Shinohara, Mito, et al.
Publicado: (2022)

Long Non-Coding RNAs and Metabolic Rewiring in Pancreatic Cancer
por: Dalmasso, Bruna, et al.
Publicado: (2023)

Early Onset Primary Hyperparathyroidism Associated with a Novel Germline Mutation in CDKN1B
por: Elston, Marianne S., et al.
Publicado: (2015)

Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma
por: Pastorino, Lorenza, et al.
Publicado: (2022)

Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting
por: Vanni, Irene, et al.
Publicado: (2023)

A germline mutation in the BRCA1 3’UTR predicts Stage IV breast cancer
por: Dorairaj, Jemima J, et al.
Publicado: (2014)

A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population
por: Mir, Rashid, et al.
Publicado: (2018)

Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With BCOR-CCNB3 Fusion and Germline CDKN2B Variant
por: Tramontana, Timothy F., et al.
Publicado: (2020)

The endogenous mex-3 3´UTR is required for germline repression and contributes to optimal fecundity in C. elegans
por: Albarqi, Mennatallah M. Y., et al.
Publicado: (2021)

Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom
por: Harland, Mark, et al.
Publicado: (2014)

Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report
por: Jeong, Ah-Reum, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hpk00q4h1n6bi5111m3v070cb8